Safety of Sugammadex for the Reversal of Neuromuscular Blockade in American Society of Anesthesiologists (ASA) Class 3 or 4 Participants (MK-8616-145)
Clinical trial NCT03346057 · COMPLETED
Trial details
- NCT number
- NCT03346057
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-20
- Primary completion
- 2019-09-04
- Enrollment
- 344
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.